We are currently enrolling qualified applicants age 18 and older into a study of an investigational medication for individuals who have Type II Diabetes.
The investigational medication is in the form of a subcutaneous injection (injection just under the skin) received once daily. The purpose of this study is to compare the effectiveness of the investigational medication to standard of care medication in the lowering of blood sugar. Study participants will receive either the investigational medication or be assigned to use the standard of care medication. All participants will receive Type II Diabetes medication as there is not a placebo (A pill, capsule, or injection that has no medicinal properties) being used in this study.
Your first visit to the research clinic will be a screening visit. During this visit you will meet with a study coordinator to fully review study details. If you decide to participate, a more in depth assessment of your health will take place to determine your final eligibility. If you are eligible and choose to enroll, you will be required to return to our research clinic various times for treatment and follow-up visits.
Space in the study is limited. Health insurance is not required. All clinical visits, medications, and physical exams are provided at no cost to you. Reimbursement for time and travel may be available.
Please complete the information below to see if you pre-qualify for the study. All information you provide to Aspen Clinical Research will remain strictly confidential.
For more in-depth information regarding this study please click HERE.
Disclaimer: Not all individuals that complete the on-line questionnaire will qualify for the study. An in-depth study and medical evaluation must be completed in person in order to qualify for the study.
